The following FAQs address key research considerations for studying the GLO4 protein and its associated antibodies in experimental settings, synthesized from available structural, functional, and methodological data.
Implement dual epitope tagging (e.g., HA/FLAG tags) alongside native antibody detection to distinguish endogenous GLO4 from overexpression artifacts.
Use domain mapping informed by InterProScan analysis (Table 1) to design blocking peptides for competitive assays.
| Domain Coordinates | Accession ID | Description | Source |
|---|---|---|---|
| 12-189 | IPR001279 | Glutathione peroxidase-like | InterPro |
| 205-320 | IPR019479 | Thioredoxin fold | InterPro |
Audit normalization methods: Compare SILAC-MS datasets (e.g., molecules/cell vs. arbitrary units).
Control for strain-specific variation: Cross-reference data from >20 studies in the SGD Protein Abundance table .
Evaluate post-translational modifications (e.g., phosphorylation at Ser-158) that alter antibody binding efficiency .
Target disordered regions (residues 85-95) predicted to be surface-exposed for enhanced antibody accessibility.
Avoid epitopes overlapping catalytic sites (Cys-42 and Cys-89) to preserve enzymatic function in functional assays .
Pre-treat cells with 0.1% Triton X-100 to improve antibody penetration through the cell wall.
Combine with GFP-tagged GLO4 strains (available via YeastGFP database) for orthogonal validation .
Use structured illumination microscopy (SIM) to resolve punctate cytoplasmic localization patterns.
Test oxidative stress conditions (e.g., H<sub>2</sub>O<sub>2</sub> exposure) that upregulate GLO4 expression 2.3-fold (Table 2).
Analyze half-life data: GLO4 exhibits a 43-minute half-life under standard conditions but stabilizes to >120 minutes during stress .
| Treatment | Fold Change | Time (min) | Reference |
|---|---|---|---|
| 1 mM H<sub>2</sub>O<sub>2</sub> | +2.3 | 60 | |
| Heat shock (42°C) | +1.8 | 30 |